Manitol Braun (Mannitol)

Mannitol is a highly osmotic sugar alcohol that remains largely in the extracellular space after IV administration. By increasing plasma osmolarity, it creates an osmotic gradient that pulls water out of cells and interstitial tissue into the vascular compartment, leading to plasma expansion, increased renal perfusion, and enhanced urine output while decreasing pressure in the brain and eye.

The dose of Manitol Braun is individualized by the prescribing clinician based on the patient’s weight, the severity of the condition, renal function, and response to therapy. Dosing regimens are not standardized in public literature and must be set by a qualified healthcare professional in accordance with local guidelines and patient-specific factors.

Mannitol Braun is classified as pregnancy category unknown, and limited data exist on its use in pregnant or lactating women. The potential benefits must be weighed against possible risks, and the decision to use the product during pregnancy or breastfeeding should be made by the treating physician after careful consideration of the clinical situation.

To order Manitol Braun, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Both mannitol and hypertonic saline act as osmotic agents, but mannitol is a sugar alcohol that is freely filtered by the kidneys and primarily increases plasma osmolarity without adding sodium. Hypertonic saline raises both sodium and osmolarity, which can be advantageous in certain electrolyte disorders. Choice of agent depends on the clinical context, renal function, and electrolyte considerations.

Manitol Braun should be stored at ambient temperature, preferably below 25 °C. Keep the solution in its original packaging, protect it from direct sunlight, moisture, and extreme temperature fluctuations. Do not freeze the product, and ensure the container remains sealed until use to maintain sterility.

Manitol Braun is administered intravenously, typically as a sterile solution that may be diluted with compatible IV fluids. The infusion rate is controlled by the prescriber, often starting with a slow bolus followed by a maintenance infusion, and the patient’s vital signs and laboratory values are monitored throughout the administration.

The most serious risks include pulmonary edema, severe dehydration, acute renal failure, and anaphylactic reactions. These events are rare but can be life‑threatening and require immediate medical intervention. Monitoring of fluid balance, renal function, and respiratory status is essential to detect early signs of these complications.

Manitol Braun is contraindicated in patients with known hypersensitivity to mannitol, severe dehydration, active intracranial bleeding, uncontrolled heart failure, or severe renal impairment where diuresis may worsen kidney function. Clinicians should also exercise caution in patients with pulmonary edema or those receiving concurrent nephrotoxic medications.